Aligos Therapeutics, Inc.

ALGS - CIK 0001799448

Market cap-

Rank-

SEC filings334

ALGS balance sheet (annual)

The table below shows Aligos Therapeutics, Inc.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.

Line item	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Cash & equivalents	$18.30M	$37.00M	$135.70M	$81.35M	$186.82M	$220.38M
Short-term investments	$59.54M	$19.94M	$44.48M	$44.48M	$3.92M	$23.13M
Receivables	-	-	-	-	-	-
Inventory	-	-	-	-	-	-
Total current assets

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.